AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
SOLIFENACIN SUCCINATE in Zimbabwe
5 products registered with MCAZ β 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| BLACIDEC 10 TABLET, COATED; ORAL | 2022/21.7/6289 | MSN LABORATORIES PRIVATE LIMITED | active | 28 Aug 2029 |
| BLACIDEC 5 TABLET, COATED; ORAL | 2022/21.7/6288 | MSN LABORATORIES PRIVATE LIMITED | active | 28 Aug 2029 |
| GOAB 5 TABLET; ORAL | 2024/21.7/6642 | HETERO LABS LTD | active | 14 Jun 2029 |
| GOAB 10 TABLET; ORAL | 2024/21.7/6643 | HETERO LABS LTD | active | 14 Jun 2029 |
| SOLUTRA-5 TABLET, COATED; ORAL | 2026/21.7/7358 | PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD | active | 31 Dec 2027 |
SOLIFENACIN SUCCINATE β MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing SOLIFENACIN SUCCINATE, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track SOLIFENACIN SUCCINATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.